Отчеты о клинических и медицинских случаях

Liver transplantation is presently the treatment of different for patients laid low with the complications of end-stage wellness, acute liver failure, and initial organ malignancy. Over the last twenty years, as a result of the success of liver transplant exaggerated, the number of patients seeking liver transplant has put together steady exaggerated. Management of chronic medical conditions and their risk issue modifications unit crucial to verify continued wonderful graft perform and overall survival Liver transplantation is indicated for the treatment of all causes of end-stage wellness, complications of decompensated liver disease of the liver, unexpected organ failure, metabolic syndromes of organ origin, and initial organ malignancies.

Contrast-enhanced ultrasound (CEUS) of the GI tract provides complex body part knowledge helpful for characterizing heaps and completely different pathologies in and around the viscous, quite like distinction applications in several solid organs. However, the use of tiny bubble distinction agents for the viscous provides additional distinctive contributions as a result of it provides every subjective and objective knowledge regarding mural and serosa blood flow, valuable for the determination of malady activity in those many patients stricken with inflammatory viscous malady (IBD). IBD could also be a long chronic malady and has its peak age of onset in adolescence or young adult life. Today, we have got stirred faraway from treating patient’s symptoms and try instead to vary the course of malady by obtaining animal tissue healing. Expensive and aggressive life therapies and lack of agreement of patient’s symptoms with their malady activity and complications necessitate frequent imaging investigation, that ought to be safe, promptly out there, cheap, and effective. Ultrasound with the nice factor concerning distinction sweetening meets these desires and is shown in meta-analysis to be like CT and MRI scans for these indications

.

Paraganglioma are rare type of neuroendocrine tumors that arise from embryonic neural crest. Paraganglioma of adrenal medulla is known as Pheochromocytoma. Extra-adrenal localization is observed in 5-10% of all paragangliomas, which can extend from upper cervical region to pelvis related to autonomic nervous system in a functional, secreting catecholamines, or non-functional phenotypes. Bladder paraganglioma is outside the usual distribution of paraganglionic tissue accounting for <0.05% of all bladder tumors. Nonfunctional paraganglioma of the bladder (NPB) and urothelial carcinoma of the bladder (UCB) are subtypes of bladder tumors, but which are entirely different entities with distinct tissue origins and anatomical locations. However due to the similarities in their clinical features and cystoscopic features NPB is often misdiagnosed as UCB whose therapeutic approach and prognosis are completely different. We present a case of paraganglioma in a 45-year-old male presenting with haematuria. Clinical provisional diagnosis rendered based on cystoscopic findings and radiology was urothelial carcinoma; however, was confirmed to be a case of paraganglioma of bladder on histopathological and immunohistochemical evaluation. Cystoscopic biopsy is of high diagnostic value, which should be considered in the preoperative diagnosis of NPB.

Tumors that are cancerous produce substances that cause organ systems in the body to behave improperly. This harm could be irreversible if not treated. The immune system is also involved in the potential damage to healthy cells. Gynecological malignancies have been linked to a number of paraneoplastic diseases. These disorders are caused by chemicals released by the tumour or a cancer-induced immune response. Different syndromes can affect each system of the human body. The neurological, ophthalmologic, dermatologic, rheumatologic, endocrine, hematologic, and renal systems have all been identified to be involved in paraneoplastic syndromes caused by gynaecologic tract malignancies. These syndromes can appear before, during, or after a cancer diagnosis. They can also happen during a recurrence. Physicians caring for cancer patients should be aware of these syndromes since they can cause substantial morbidity and must be treated correctly.